Market Cool On Marinus Pharmaceuticals, Inc.'s (NASDAQ:MRNS) Revenues Pushing Shares 80% Lower

Simply Wall StOct 29 08:51 ET

12 Health Care Stocks Moving In Monday's Pre-Market Session

BenzingaOct 28 08:07 ET

Marinus Pharma Analyst Ratings

BenzingaOct 25 15:45 ET · Ratings

Catalyst Watch: Eyes on Tech With Apple, Amazon, Alphabet, and Meta Reporting

Seeking AlphaOct 25 15:00 ET

TD Cowen Downgrades Marinus Pharma to Hold

BenzingaOct 25 14:50 ET

Marinus Pharmaceuticals Price Target Cut to $1.00/Share From $3.00 by RBC Capital

Dow JonesOct 25 13:37 ET · Ratings